Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sacha Gnjatic

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Immunogenic targets in non-small cell lung cancer: more is moreSacha Gnjatic
Nature Reviews. Clinical Oncology|November 20, 2025
Could a COVID-19 vaccine improve the effectiveness of cancer immunotherapy?Sacha Gnjatic
Nature Medicine|April 6, 2013
Antigen depots: T cell traps?Sacha Gnjatic, Nina Bhardwaj
Oncoimmunology|June 28, 2012
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapyTakemasa Tsuji, Sacha Gnjatic
Nature Nanotechnology|September 7, 2017
Cancer Immunotherapy: From local to globalWillem J M Mulder, Sacha Gnjatic
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Toll-like receptor agonists: are they good adjuvants?Sacha Gnjatic, Nikhil B Sawhney, Nina Bhardwaj
Oncoimmunology|October 24, 2014
Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILsLeah Alabanza, Sacha Gnjatic, Nina Bhardwaj, et al.
Nature Reviews. Cancer|March 15, 2019
Host tissue determinants of tumour immunityHélène Salmon, Romain Remark, Sacha Gnjatic, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 22, 2009
Autoantibodies against cancer antigensSacha Gnjatic, Lloyd J Old, Yao-Tseng Chen
Frontiers in Immunology|March 11, 2015
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor ImmunityClaire Germain, Sacha Gnjatic, Marie-Caroline Dieu-Nosjean
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Immunogenic targets in non-small cell lung cancer: more is moreSacha Gnjatic
Nature Reviews. Clinical Oncology|November 20, 2025
Could a COVID-19 vaccine improve the effectiveness of cancer immunotherapy?Sacha Gnjatic
Nature Medicine|April 6, 2013
Antigen depots: T cell traps?Sacha Gnjatic, Nina Bhardwaj
Oncoimmunology|June 28, 2012
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapyTakemasa Tsuji, Sacha Gnjatic
Nature Nanotechnology|September 7, 2017
Cancer Immunotherapy: From local to globalWillem J M Mulder, Sacha Gnjatic
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Toll-like receptor agonists: are they good adjuvants?Sacha Gnjatic, Nikhil B Sawhney, Nina Bhardwaj
Oncoimmunology|October 24, 2014
Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILsLeah Alabanza, Sacha Gnjatic, Nina Bhardwaj, et al.
Nature Reviews. Cancer|March 15, 2019
Host tissue determinants of tumour immunityHélène Salmon, Romain Remark, Sacha Gnjatic, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 22, 2009
Autoantibodies against cancer antigensSacha Gnjatic, Lloyd J Old, Yao-Tseng Chen
Frontiers in Immunology|March 11, 2015
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor ImmunityClaire Germain, Sacha Gnjatic, Marie-Caroline Dieu-Nosjean
Pageof 29